IVZNYSESEC EDGAREDGAR

Invesco Ltd.

Investment Advice·ATLANTA, GA·FY end 12/31·CIK 914208

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$6.4B$6.1B$5.7B$6.0B$6.9B
Gross Profit
Operating Income-$695.7M$832.1M-$434.8M$1.3B$1.8B
Net Income$538.0M-$333.7M$683.9M$1.4B
Operating CF$1.5B$1.2B$1.3B$703.2M$1.1B
Capex$84.3M$69.1M$164.3M$192.9M$108.8M
Free Cash Flow$1.4B$1.1B$1.1B$510.3M$969.3M
Buybacks$123.6M$79.3M$187.5M
Dividends$377.3M$371.5M$357.9M$334.8M$307.7M
Gross Margin
Operating Margin-10.9%13.7%-7.6%21.8%25.9%
Net Margin8.9%-5.8%11.3%20.2%
FCF Margin22.6%18.5%19.9%8.4%14.1%
R&D / Revenue
Effective Tax53.9%25.2%29.3%25.8%21.2%
Debt / Equity0.150.060.100.100.13
Buybacks / FCF8.6%7.1%16.5%

Peer comparison

Investment Advice · 5 peers
CEO Pay Ratio
IVZ
133:1
HLNE
613:1
ARES
346:1
JHG
194:1
TPG
9:1
BEN
113:1
CEO total comp
IVZ
$16M
HLNE
$80M
ARES
$68M
JHG
$35M
TPG
$30M
BEN
$17M
Net Margin
IVZ
HLNE
30.5%
ARES
11.1%
JHG
TPG
4.0%
BEN
6.0%